Penn Medicine Provider
About me
- Director, Philadelphia VA Center of Excellence in Substance Addiction Treatment and Education (CESATE)
- Professor of Psychiatry
My area of expertise is alcohol and drug use disorders. I provide individual treatment through the Charles O'Brien Center here at Penn, and I conduct research to develop and evaluate new interventions to facilitate and support long-term recovery from substance use disorders.
Education and training
- Graduate School: Harvard University
- Residency: Boston University Hospital
- Residency: McLean Hospital
- Fellowship: Harvard University
My Locations
Charles O'Brien Center for Addiction Treatment
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Advanced Practice Provider
Qualifications and experience
- American Psychological Association,
- College on Problems of Drug Dependence,
- National Institute of Mental Health SBIR grant review committee,
- National Institute on Drug Abuse Health Services Review Committee (NIDA-F),
- Research and Design Committee, National Institute on Alcohol Abuse and,
- Research Society on Alcoholism,
My research
DePhilippis D, Khazanov G, Christofferson DE, Wesley CW, Burden JL, Liberto J, McKay JR. History and current status of contingency management programs in the Department of Veterans Affairs , Prev Med: 2023
Blanchard BE, Lynch KG, Malte CA, Hawkins EJ, DePhilippis D, Oslin DW, McKay JR, Saxon AJ. Towards shortening the Brief Addiction Monitor-Revised (BAM-R) , Drug Alcohol Depend Rep, 8: 2023,100183
Bhattacharya I, Johnson BA, Artman WJ, Wilson A, Lynch KG, McKay JR, Ertefaie A. A non-parametric Bayesian approach for adjusting partial compliance in sequential decision making , Stat Med, 42: 2023,2661-2691
Yap J, J Dziak J, Maiti R, Lynch K, McKay JR, Chakraborty B, Nahum-Shani I. Sample size estimation for comparing dynamic treatment regimens in a SMART: A Monte Carlo-based approach and case study with longitudinal overdispersed count outcomes , Stat Methods Med Res: 2023
Kelly PJ, Ingram I, Deane FP, Baker AL, Byrne G, Degan T, Osborne B, Meyer JM, Townsend C, Nunes J, McKay JR, Robinson L, Nolan E, Palazzi K, Lunn J. Feasibility and preliminary results of a call centre delivered continuing care intervention following residential alcohol and other drug treatment , Drug Alcohol Rev: 2023
Osilla KC, Gore KL, Pedersen ER, Hummer JF, DeYoreo M, Manuel JK, McKay JR, Kim JP, Nameth K. Study protocol for a sequential multiple assignment randomized trial to reduce risky drinking among service members and their partners , Contemp Clin Trials: 2023
French R, Worley J, Lowenstein M, Bogner HR, Calderbank T, DePhilippis D, Forrest A, Connolly Gibbons MB, Harris RA, Heywood S, Kampman K, Mandell DS, McKay JR, Newman ST, Oslin DW, Wadden S, Wolk CB. Adapting psychotherapy in collaborative care for treating opioid use disorder and co-occurring psychiatric conditions in primary care , Fam Syst Health: 2023
Bhattacharya I, Ertefaie A, Lynch KG, McKay JR, Johnson BA. Nonparametric Bayesian Q-learning for optimization of dynamic treatment regimes in the presence of partial compliance , Stat Methods Med Res: 2023
Dugosh KL, Lent MR, Burkley SB, Millard CMK, McKay JR, Kampman KM. Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment , J Addict Med: 2023
Fivecoat HC, Lookatch SJ, Mavandadi S, McKay JR, Sayers SL. Social Factors Predict Treatment Engagement in Veterans with PTSD or SUD , J Behav Health Serv Res: 2023